• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EFNS-ENS 指南:痴呆相关疾病的诊断与管理。

EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia.

机构信息

Department of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy.

出版信息

Eur J Neurol. 2012 Sep;19(9):1159-79. doi: 10.1111/j.1468-1331.2012.03784.x.

DOI:10.1111/j.1468-1331.2012.03784.x
PMID:22891773
Abstract

BACKGROUND AND OBJECTIVES

The last version of the EFNS dementia guidelines is from 2007. In 2010, the revised guidelines for Alzheimer's disease (AD) were published. The current guidelines involve the revision of the dementia syndromes outside of AD, notably vascular cognitive impairment, frontotemporal lobar degeneration, dementia with Lewy bodies, corticobasal syndrome, progressive supranuclear palsy, Parkinson's disease dementia, Huntington's disease, prion diseases, normal-pressure hydrocephalus, limbic encephalitis and other toxic and metabolic disorders. The aim is to present a peer-reviewed evidence-based statement for the guidance of practice for clinical neurologists, geriatricians, psychiatrists and other specialist physicians responsible for the care of patients with dementing disorders. It represents a statement of minimum desirable standards for practice guidance.

METHODS

The task force working group reviewed evidence from original research articles, meta-analyses and systematic reviews, published by June 2011. The evidence was classified (I, II, III, IV) and consensus recommendations graded (A, B, or C) according to the EFNS guidance. Where there was a lack of evidence, but clear consensus, good practice points were provided.

RESULTS AND CONCLUSIONS

New recommendations and good practice points are made for clinical diagnosis, blood tests, neuropsychology, neuroimaging, electroencephalography, cerebrospinal fluid (CSF) analysis, genetic testing, disclosure of diagnosis, treatment of behavioural and psychological symptoms in dementia, legal issues, counselling and support for caregivers. All recommendations were revised as compared with the previous EFNS guidelines. The specialist neurologist together with primary care physicians play an important role in the assessment, interpretation and treatment of symptoms, disability and needs of dementia patients.

摘要

背景与目的

欧洲神经病学会(EFNS)的最新一版痴呆症指南是在 2007 年发布的。2010 年,阿尔茨海默病(AD)修订版指南发布。当前的指南涉及到 AD 以外的痴呆综合征的修订,特别是血管性认知障碍、额颞叶痴呆、路易体痴呆、皮质基底节综合征、进行性核上性麻痹、帕金森病痴呆、亨廷顿病、朊病毒病、正常压力脑积水、边缘性脑炎和其他毒性和代谢性疾病。目的是为临床神经科医生、老年病学家、精神科医生和其他负责痴呆患者护理的专科医生提供一份经过同行评审的基于证据的声明,以指导实践。它代表了实践指导最低理想标准的陈述。

方法

工作组审查了截至 2011 年 6 月发表的原始研究文章、荟萃分析和系统评价的证据。根据 EFNS 指南对证据进行分类(I、II、III、IV)并对共识建议进行分级(A、B 或 C)。在缺乏证据但有明确共识的情况下,提供了良好的实践要点。

结果与结论

针对临床诊断、血液检查、神经心理学、神经影像学、脑电图、脑脊液(CSF)分析、基因检测、诊断披露、痴呆患者行为和心理症状的治疗、法律问题、对护理人员的咨询和支持,提出了新的建议和良好的实践要点。与之前的 EFNS 指南相比,所有建议都进行了修订。专科神经科医生与初级保健医生一起,在评估、解释和治疗痴呆患者的症状、残疾和需求方面发挥着重要作用。

相似文献

1
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia.EFNS-ENS 指南:痴呆相关疾病的诊断与管理。
Eur J Neurol. 2012 Sep;19(9):1159-79. doi: 10.1111/j.1468-1331.2012.03784.x.
2
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline.阿尔茨海默病及其他痴呆相关疾病的诊断与管理建议:欧洲神经科学联合会指南
Eur J Neurol. 2007 Jan;14(1):e1-26. doi: 10.1111/j.1468-1331.2006.01605.x.
3
EFNS guidelines for the diagnosis and management of Alzheimer's disease.EFNS 指南:阿尔茨海默病的诊断与管理。
Eur J Neurol. 2010 Oct;17(10):1236-48. doi: 10.1111/j.1468-1331.2010.03040.x.
4
CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.脑脊液生物标志物可区分特发性正常压力脑积水与其类似疾病。
J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1117-1123. doi: 10.1136/jnnp-2019-320826. Epub 2019 Jun 5.
5
The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia.经颅磁刺激在痴呆诊断和管理中的作用。
Clin Neurophysiol. 2014 Aug;125(8):1509-32. doi: 10.1016/j.clinph.2014.04.010. Epub 2014 Apr 30.
6
Neuroimaging biomarkers of neurodegenerative diseases and dementia.神经退行性疾病和痴呆的神经影像学生物标志物。
Semin Neurol. 2013 Sep;33(4):386-416. doi: 10.1055/s-0033-1359312. Epub 2013 Nov 14.
7
The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.早发性痴呆的临床诊断:诊断准确性与临床病理关系。
Brain. 2011 Sep;134(Pt 9):2478-92. doi: 10.1093/brain/awr189. Epub 2011 Aug 11.
8
Differential diagnosis of Alzheimer's disease.阿尔茨海默病的鉴别诊断。
Neurology. 1997 May;48(5 Suppl 6):S2-9. doi: 10.1212/wnl.48.5_suppl_6.2s.
9
EFNS task force: the use of neuroimaging in the diagnosis of dementia.EFNS 工作组:神经影像学在痴呆诊断中的应用。
Eur J Neurol. 2012 Dec;19(12):e131-40, 1487-501. doi: 10.1111/j.1468-1331.2012.03859.x. Epub 2012 Aug 20.
10
Clinical workout for the early detection of cognitive decline and dementia.用于早期检测认知功能衰退和痴呆的临床检查
Eur J Clin Nutr. 2014 Nov;68(11):1186-91. doi: 10.1038/ejcn.2014.189. Epub 2014 Oct 1.

引用本文的文献

1
AI-based staging, causal hypothesis and progression of subjects at risk of Alzheimer's disease: a multicenter study.基于人工智能的阿尔茨海默病高危受试者的分期、因果假设及病情进展:一项多中心研究
Front Neurol. 2025 May 19;16:1568086. doi: 10.3389/fneur.2025.1568086. eCollection 2025.
2
Effective for Whom? A Review of Psychological and Social Intervention Recommendations in European Dementia Care Guidelines Through the Lenses of Social Health and Intersectionality.对谁有效?从社会健康和交叉性视角审视欧洲痴呆症护理指南中的心理和社会干预建议
Behav Sci (Basel). 2025 Apr 2;15(4):457. doi: 10.3390/bs15040457.
3
Elapsed time changes of the brain radiopharmaceutical accumulation of the amyloid PET examination using F-flutemetamol.
使用F-氟代甲磺酸美他莫的淀粉样蛋白PET检查中脑放射性药物积聚的时间变化。
Ann Nucl Med. 2025 Jul;39(7):732-746. doi: 10.1007/s12149-025-02046-3. Epub 2025 Apr 19.
4
Federated learning with multi-cohort real-world data for predicting the progression from mild cognitive impairment to Alzheimer's disease.利用多队列真实世界数据进行联邦学习以预测从轻度认知障碍到阿尔茨海默病的进展
Alzheimers Dement. 2025 Apr;21(4):e70128. doi: 10.1002/alz.70128.
5
Clinical utility of cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic workup of complex patients with cognitive impairment.脑脊液阿尔茨海默病生物标志物在复杂认知障碍患者诊断检查中的临床应用
Transl Psychiatry. 2025 Apr 7;15(1):130. doi: 10.1038/s41398-025-03345-z.
6
Behavioural and psychological symptoms among out-patients with different cognitive states: cross-sectional study.不同认知状态门诊患者的行为和心理症状:横断面研究
BJPsych Open. 2025 Apr 1;11(3):e73. doi: 10.1192/bjo.2025.7.
7
Social cognition in mild cognitive impairment and dementia: A systematic review and meta-analysis.轻度认知障碍和痴呆中的社会认知:系统评价与荟萃分析。
Alzheimers Dement. 2025 Mar;21(3):e70076. doi: 10.1002/alz.70076.
8
Clinical practice guidelines on addressing cognitive impairment in treatable dementias.关于治疗可治性痴呆中认知障碍的临床实践指南。
Indian J Psychiatry. 2025 Jan;67(1):41-53. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_684_24. Epub 2025 Jan 13.
9
Neuropathological contributions to grey matter atrophy and white matter hyperintensities in amnestic dementia.遗忘型痴呆中灰质萎缩和白质高信号的神经病理学贡献。
Alzheimers Res Ther. 2025 Jan 9;17(1):16. doi: 10.1186/s13195-024-01633-2.
10
The Association Between Brain Metabolic Biomarkers Using F-FDG and Cognition and Vascular Risk Factors, as well as Its Usefulness in the Diagnosis and Staging of Alzheimer's Disease.使用F-FDG的脑代谢生物标志物与认知及血管危险因素之间的关联及其在阿尔茨海默病诊断和分期中的应用价值。
J Alzheimers Dis Rep. 2024 Sep 5;8(1):1229-1240. doi: 10.3233/ADR-240104. eCollection 2024.